Neuralink announced first-in-human clinical trial
Before they tested only on pigs and monkeys. But in May 2023 Neuralink got FDA approval for in-human trials. And they are looking for candidates to put chips into their brains!
So, PRIME study! PRIME is Precise Robotically Implanted Brain-Computer Interface. It aims to evaluate the safety and effectiveness of three key components: the N1 Implant (a BCI implant), the R1 Robot (a surgical tool), and the N1 User App (BCI software). These devices are experimental and not commercially available.
- The N1 Implant is surgically placed in the brain to record and transmit neural activity. It's designed to help individuals control computers.
- The R1 Robot is responsible for precise implantation of the N1 threads in the brain.
Sounds cyberpunkish.
Who Can Participate?
The study is looking for individuals with quadriplegia due to spinal cord injury or ALS, who meet specific eligibility criteria. However, it's important to note that certain medical conditions may disqualify potential participants.
Time Commitment
This isn't a short-term commitment. The study spans approximately 6 years, involving clinic visits, research sessions, and long-term follow-ups.
How to Get Involved
If you or someone you know may be eligible and interested, you can find more information and register at neuralink.com/patient-registry
The PRIME Study represents a fascinating intersection of science and technology. While it's crucial to stay grounded, I can't help but be curious about the potential of BCIs. It's a field worth watching as it unfolds and evolves. And of course what comes to my mind: can we pair this with LLMs?..
That all reminded me of the beautiful quote from Hugh Herr (director of the Biomechatronics Group at The MIT Media Lab): “I reasoned that a human being can never be "broken." Technology is broken.” He said that in his TED Talk speech while standing on two mechanical leg implants back in 2014. It is a great talk about the transformative power of bionics and how they are reshaping the future of human abilities. Worth watching.